| Data | Descrição | Vacina | Quantidade 1° dose | Quantidade 2° dose | Quantidade 1° dose extra | Quantidade 2° dose extra | Quantidade de doses indigena | Total |
| 31/01/2022 | 219VCD288Z | Fiocruz/Oxford/AstraZeneca | 0 | 0 | 0 | 0 | 0 | 165 |
| 03/02/2022 | 210461 | Butantan/CoronaVac | 25 | 25 | 0 | 0 | 0 | 50 |
| 03/02/2022 | 210439A | Butantan/CoronaVac | 60 | 60 | 0 | 0 | 0 | 120 |
| 03/02/2022 | FP8290 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 60 | 60 | 0 | 0 | 0 | 120 |
| 07/02/2022 | 2019VCD292Z | Fiocruz/Oxford/AstraZeneca | 0 | 0 | 0 | 0 | 0 | 200 |
| 11/02/2022 | C202107128 | Butantan/CoronaVac | 15 | 0 | 0 | 0 | 0 | 15 |
| 11/02/2022 | FN5988 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 120 | 0 | 0 | 0 | 0 | 120 |
| 14/02/2022 | 219VCD292Z | Fiocruz/Oxford/AstraZeneca | 0 | 0 | 0 | 0 | 0 | 50 |
| 14/02/2022 | 205F21A | Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag | 0 | 0 | 0 | 0 | 0 | 150 |
| 14/02/2022 | FM2951 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 150 |
| 21/02/2022 | C202107131 | Butantan/CoronaVac | 342 | 0 | 0 | 0 | 0 | 342 |
| 21/02/2022 | FRB392 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 90 | 0 | 0 | 0 | 90 |
| 22/02/2022 | 21OVCD300Z | Fiocruz/Oxford/AstraZeneca | 0 | 0 | 0 | 0 | 0 | 200 |
| 22/02/2022 | 201H21A | Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag | 0 | 0 | 0 | 0 | 0 | 100 |
| 22/02/2022 | FM2948 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 72 |
| 03/03/2022 | 21OVCD016VA | Fiocruz/Oxford/AstraZeneca | 0 | 0 | 0 | 0 | 0 | 200 |
| 03/03/2022 | 201H21A | Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag | 0 | 0 | 0 | 0 | 0 | 100 |
| 03/03/2022 | FM2948 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 72 |
| 03/03/2022 | C202107128 | Butantan/CoronaVac | 0 | 0 | 0 | 0 | 0 | 123 |
| 03/03/2022 | 21OVCD016VA | Fiocruz/Oxford/AstraZeneca | 0 | 0 | 0 | 0 | 0 | 200 |
| 03/03/2022 | 201H21A | Janssen Covid-19 Vaccine | 0 | 0 | 0 | 0 | 0 | 100 |
| 03/03/2022 | FM2948 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 72 |
| 03/03/2022 | 210525 | Butantan/CoronaVac | 0 | 0 | 0 | 0 | 0 | 170 |
| 08/03/2022 | 21OVCD016VA | Fiocruz/Oxford/AstraZeneca | 0 | 0 | 0 | 0 | 0 | 200 |
| 08/03/2022 | 201H21A | Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag | 0 | 0 | 0 | 0 | 0 | 200 |
| 08/03/2022 | FN2948 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 90 |
| 08/03/2022 | C202107128 | Butantan/CoronaVac | 0 | 15 | 0 | 0 | 0 | 15 |
| 08/03/2022 | FR83292 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 60 | 0 | 0 | 0 | 60 |
| 08/03/2022 | 21OVCD016VA | Fiocruz/Oxford/AstraZeneca | 0 | 0 | 0 | 0 | 0 | 200 |
| 08/03/2022 | 201H21A | Janssen Covid-19 Vaccine | 0 | 0 | 0 | 0 | 0 | 200 |